Fingerprint
Dive into the research topics of 'Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer
Huiyuan Wang, Feng Li, Chengan Du, Huixin Wang, Ram I. Mahato, Yongzhuo Huang
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations